New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 9, 2014
07:10 EDTBABYNatus Medical announce share repurchase program
Natus Medical announced that its board has approved a stock repurchase program authorizing the repurchase of up to $10M of the company's common stock. There is no set expiration date for the program. The primary objective of the share repurchase program is to offset the impact of dilution from issuances relating to employee equity grants and the company's employee stock purchase program. The company intends to use cash on hand, cash generated from operations, existing credit facilities or other financing to fund the share repurchase program. As of March 31, the company had cash and cash equivalents of approximately $60M and availability under an existing line of credit of $25M.
News For BABY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2015
07:08 EDTBABYNatus Medical raises FY15 EPS view to $1.42-$1.46 from $1.40-$1.44
Consensus $1.44. Raises FY15 revenue guidance to $373M-$375M from $367M-$369M, consensus $367.05M.
07:06 EDTBABYNatus Medical backs Q1 EPS view of 28c-30c, consensus 29c
Subscribe for More Information
07:05 EDTBABYNatus Medical reports Q4 EPS 40c, consensus 39c
Subscribe for More Information
January 26, 2015
07:05 EDTBABYNatus Medical acquires Global Neuro-Diagnostics
Natus Medical announced that it has entered the neurodiagnostic services market through the acquisition of Global Neuro-Diagnostics, or GND. GND was profitable in 2014 with revenue of approximately $7M. GND's service offers patients a more convenient way to complete routine video EEG testing which can be performed at the home, hospital or physician's office. The service also provides comprehensive reporting and support to the physician.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use